In its new series of reports on antibacterial markets, Expert Market Research, one of the world’s leading providers of lifescience market intelligence, analyses the market potential of antibacterial drugs in key emerging markets.
EMR’s antibacterial drug market series includes reports on the following countries:
• China Antibacterial Market Report and Forecast: 2011-2016
• Turkey Antibacterial Market Report and Forecast: 2011-2016
• South Korea Antibacterial Market Report and Forecast: 2011-2016
• Mexico Antibacterial Market Report and Forecast: 2011-2016
• Brazil Antibacterial Market Report and Forecast: 2011-2016
• Indonesia Antibacterial Market Report and Forecast: 2011-2016
• Thailand Antibacterial Market Report and Forecast: 2011-2016
• Egypt Antibacterial Market Report and Forecast: 2011-2016
• Saudi Arabia Antibacterial Market Report and Forecast: 2011-2016
• Australia Antibacterial Market Report and Forecast: 2011-2016
• South Africa Antibacterial Market Report and Forecast: 2011-2016
• Argentina Antibacterial Market Report and Forecast: 2011-2016
• Vietnam Antibacterial Market Report and Forecast: 2011-2016
• Russia Antibacterial Market Report and Forecast: 2011-2016
• India Antibacterial Market Report and Forecast: 2011-2016
Each of these reports provide a comprehensive analysis of the current and future market trends in the antibacterial drugs market. These reports can serve as an excellent guide for clients who are in need of an in-depth understanding of the market for antibacterial drugs.
Key Questions Answered in these Reports:
• What has been the historical performance of the antibacterial market and how will it behave in the coming years?
• Who are the leading companies in the antibacterial market and how will they perform in the coming years?
• What has been the historical performance of various antibacterial therapeutic classes and how will they behave in the coming years?
• What are the leading molecules in the antibacterial market and how will they behave in the coming years?
Why should you buy these Reports?
• To facilitate business decision-making based on historical, current and forecast market data for antibacterial drugs
• To identify potential classes, drugs, partners and competitors so as to develop strategies for market penetration and drug development
• To develop business strategies by looking at companies that have been the biggest winners and losers in the antibacterial market.
• To gain an understanding into future market events and make more informed business decisions.
Research Objectives Achieved in these Reports:
Comprehensive Situation Analysis of the Antibacterial Markets:
Classes Covered: Oral Cephalosphorins, Injectable Cephalosphorins, Oral Fluoroquinolones, Injectable Fluoroquinolones, Macrolides, Oral Broad Spectrum Penicillins, Injectable Broad Spectrum Penicillins, Penems & Carbapenems, Tetracyclines & Combinations and all other Antibacterials.
Key Aspects Analyzed:
• Historical, current and future market trends
• Historical, current and future performance of various drugs
• Historical, current and future performance of various companies.
• Product portfolio of various companies
• Historical, current and future performance of various therapeutic classes
Methodology & Information Sources:
To prepare this report, material was mined from both primary and secondary data sources. Primary information sources included data provided by pharmaceutical manufacturers, marketing strategists, scientists, doctors and product managers at leading pharmaceutical companies. Secondary data sources include both proprietary and public databases. These included company websites, annual reports, financial reports, 10K’s, government resources, books, magazines, white papers, journals, analyst reports and access to thousands of proprietary databases.
Table of Contents
1. Research Methodology & Definitions
2. Executive Summary
3. The Antibacterial Drugs Market Landscape
3.1 Current Trends & Forecast
3.1.1 Current Market Trends
3.1.2 Market Forecast
3.2 Performance of Various Therapeutic Classes
3.2.1 Oral Cephalosphorins
3.2.1.1 Current Market Trends
3.2.1.2 Sales of Various Molecules
3.2.1.3 Sales of Key Companies
3.2.1.4 Sales Forecast
3.2.2 Injectable Cephalosphorins
3.2.2.1 Current Market Trends
3.2.2.2 Sales of Various Molecules
3.2.2.3 Sales of Key Companies
3.2.2.4 Sales Forecast
3.2.3 Oral Fluoroquinolones
3.2.3.1 Current Market Trends
3.2.3.2 Sales of Various Molecules
3.2.3.3 Sales of Key Companies
3.2.3.4 Sales Forecast
3.2.4 Injectable Fluoroquinolones
3.2.4.1 Current Market Trends
3.2.4.2 Sales of Various Molecules
3.2.4.3 Sales of Key Companies
3.2.4.4 Sales Forecast
3.2.5 Macrolides
3.2.5.1 Current Market Trends
3.2.5.2 Sales of Various Molecules
3.2.5.3 Sales of Key Companies
3.2.5.4 Sales Forecast
3.2.6 Oral Broad Spectrum Penicillins
3.2.6.1 Current Market Trends
3.2.6.2 Sales of Various Molecules
3.2.6.3 Sales of Key Companies
3.2.6.4 Sales Forecast
3.2.7 Injectable Broad Spectrum Penicillins
3.2.7.1 Current Market Trends
3.2.7.2 Sales of Various Molecules
3.2.7.3 Sales of Key Companies
3.2.7.4 Sales Forecast
3.2.8 Penems & Carbapenems
3.2.8.1 Current Market Trends
3.2.8.2 Sales of Various Molecules
3.2.8.3 Sales of Key Companies
3.2.8.4 Sales Forecast
3.3.8 Tetracyclines & Combinations
3.3.9.1 Current Market Trends
3.3.9.2 Sales of Various Molecules
3.3.9.3 Sales of Key Companies
3.3.9.4 Sales Forecast
3.3.10 All other Antibacterials
3.3.10.1 Current Market Trends
3.3.10.2 Sales of Various Molecules
3.3.10.3 Sales of Key Companies
3.3.10.4 Sales Forecast
To buy the complete report or to get a free sample:
Call: +91-880-236-2536 (Asia), +1 206 204-1851 (America & Europe)
Email: [email protected]
To know more please visit: http://www.expertmarketresearch.com
